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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S209Purpose: Non-steroidal anti-inﬂammatory agents (NSAIDs) are com-
monly used to manage symptoms in patients with knee osteoarthritis
(OA). While randomized controlled trials have demonstrated efﬁcacy,
real world effectiveness of these agents in long term studies is lacking.
This study sought to estimate the effectiveness of NSAIDs on symptom
management over 4 years among persons with radiographically con-
ﬁrmed OA. Marginal structural models, which take into consideration
the likely dual role of indices of disease severity as confounders and
intermediary variables, were compared to standard repeated-measure
analyses.
Methods: We identiﬁed NSAID naïve participants with radiographic
knee OA in the Osteoarthritis Initiative. Participants were evaluated
over 4 years. NSAID users included those reporting any use of pre-
scription medication use (i.e., either regular use or as-needed use) at
each assessment. Outcome measures included WOMAC Pain, Stiffness
and Physical Function. Beta coefﬁcients derived from marginal struc-
tural models and generalized estimating equation models represented
the average change in outcomemeasures attributed to long term NSAID
use. Minimally important clinical differences were a priori set as at least
1.2 for pain, 0.5 for stiffness, and 4.1 for function.
Results: Persons with radiographically conﬁrmed OA with long term
reports of prescription NSAIDS use experienced improvements in
WOMAC Pain: -0.99 (95% Conﬁdence Interval (CI): -2.38 to 0.4);
WOMAC Stiffness: -0.64 (95% CI: -1.52 to 0.24); and WOMAC Function:
-5.29 (95% CI: -9.7 to -0.89). In contrast, the analysis with generalized
estimating equations yields an estimate of -0.03, -0.08 and 0.07 for
difference in Pain, Stiffness and Function, respectively.
Conclusions: When evaluated using marginal structural models, long
term use of NSAIDs showed a modest trend towards relieving symp-
toms and a clinically signiﬁcant improvement in function in patients
with radiographically conﬁrmed OA, whereas a standard regression
models didn’t show such beneﬁts. Studies on the treatment of OA using
non-experimental data should consider using marginal structural
models when evaluating the overall treatment effect from a time-
varying treatment.
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Purpose: Although Total Hip Replacement (THR) is a successful surgical
intervention, there are a minority of patients who do not achieve
clinically meaningful improvement or whose symptoms get worse
following surgery. The aim of this study was to develop a clinical risk
prediction tool to predict patient reported outcomes following primary
hip replacement surgery.
Methods: We obtained data on two prospective cohorts of patients
receiving primary THR for osteoarthritis: Exeter Primary Outcomes
Study (n ¼ 1247); EUROHIP (n ¼ 845). The primary outcome was the
Oxford Hip Score (OHS). Combining data from two large prospective
cohort studies allowed us to take account of a wide and comprehensive
range of both traditional and novel risk factors, including patient,
radiographic and surgical predictors. Linear regression modelling was
used to identify predictors of outcome. For internal validationwe used a
combination of multiple imputation and bootstrapping with backward
selection. Performance of the predictive model was assessed in terms of
calibration and discrimination.
Results: Of the radiographic variables pattern of OA was an important
determinant of outcome. Those with superomedial, medial or concen-
tric disease had worse outcomes than patients with a superolateral
pattern of OA or no reduction in joint space. Arthritis in other joints, and
previous surgery on other joints, were associated with worse outcomes.For surgical variables, a posterior surgical approach, and larger femoral
component offset had better outcomes. For patient factors, worse pre-
operative pain/function, increasing age when over age 75, increasing
BMI, lower levels of educational attainment and those with worse pre-
operative SF36 mental health scores, also had worse outcomes.
These factors were operationalized into a clinical risk prediction tool.
Calibration of the predicted 12-month post-operative OHS, and abso-
lute change in OHS was good. The model showed good discriminatory
ability with a bias corrected R-squared of 23.1%. We tested the ability of
the model to identify patients with the worst possible outcomes fol-
lowing THR (deﬁned as a change in OHS < 5-points of whom 89 (4.25%)
patients met this criterion). Performance of the tool to identify patients
with the worst outcomes was good (C-statistic 0.77 95%CI (0.72 to
0.82)).
Conclusions: We have developed a clinical risk prediction tool that
would provide information on the likely outcomes of hip replacement
surgery. Following hip replacement the majority of patients do very
well, and only a minority will not achieve clinically meaningful symp-
tomatic change in OHS. The clinical tool performed well in terms of its
calibration and discriminatory ability, and identiﬁcation of those
patients with the worst possible outcomes was good. The tool provides
individualised risk prediction and allows patients to understand their
expected outcomes of surgery – it has the potential to guide patient-
clinician decision-making. It will now undergo external validation in a
new prospective cohort of patients.
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Purpose: (1) The aim of the study was to systematically summarize the
literature from March 2005 to January 2013 on the course of physical
functioning and pain in patients with OA of the knee or hip and (2) to
provide an overview of prognostic factors of physical functioning and
future pain for these patients.
Methods: A search was conducted in PubMed, CINAHL, Embase and
Psych-INFO in January 2013. Eligible studies were prospective cohort
studies (minimum follow up was  6 months) that included partic-
ipants with knee or hip OA diagnosed with radiographically and/or
